What is the optimum dose of adefovir in the treatment of chronic hepatitis B infection?
Simsek
Halis
H
Shorbagi
Ali
A
Balaban
Yasemin
Y
Tatar
Gonca
G
D000225:Adenine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006513:Hepatitis B e Antigens / Q000097:blood; D019694:Hepatitis B, Chronic / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D008297:Male; D063065:Organophosphonates / Q000627:therapeutic use*; D016896:Treatment Outcome
D000998:Antiviral Agents; D006513:Hepatitis B e Antigens; D063065:Organophosphonates; C053001:adefovir; D000225:Adenine